Immucell (ICCC) FCF Margin (2009 - 2026)
Immucell's FCF Margin came in at -7.33% for Q3 2026, up 24.93 percentage points from -32.26% a year earlier but down 39.13 percentage points from the prior quarter.
Immucell (ICCC) FCF Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Immucell reported FCF Margin of 16.27%, up 13.69 percentage points year-over-year; for FY2025, it was 4.43%, up 4.84 percentage points from FY2024.
- FCF Margin carries a five-year change of +22.40 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -0.41% in FY2024 (+37.18 pp), -37.59% in FY2023 (-7.86 pp), -29.72% in FY2022 (-21.13 pp) and -8.60% in FY2021 (+9.37 pp).
- The five-year range for quarterly FCF Margin is -99.93% (Q1 2023) to 32.79% (Q1 2026).
- Year-over-year, FCF Margin has increased for four consecutive quarters, with an average year-over-year change of +8.94 percentage points over the last seven quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2024 (a gain of 104.73 percentage points), and the weakest in Q1 2023 (a drop of 97.11 percentage points).
- Business Quant data shows ICCC's FCF Margin at 31.80% (Q2 2026), 32.79% (Q1 2026) and 4.07% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 28.96% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | -7.33% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7.33% |
| Jun 30, 2026 | 31.80% |
| Mar 31, 2026 | 32.79% |
| Dec 31, 2025 | 4.07% |
| Sep 30, 2025 | -32.26% |
| Jun 30, 2025 | 22.44% |
| Mar 31, 2025 | 15.43% |
| Dec 31, 2024 | -2.57% |
| Sep 30, 2024 | -12.11% |
| Jun 30, 2024 | 8.61% |
| Mar 31, 2024 | 4.80% |
| Sep 30, 2023 | -19.33% |
| Jun 30, 2023 | -39.34% |
| Mar 31, 2023 | -99.93% |
| Dec 31, 2022 | -71.29% |
| Sep 30, 2022 | -41.54% |
| Jun 30, 2022 | -14.76% |
| Mar 31, 2022 | -2.82% |
| Dec 31, 2021 | -2.14% |
| Sep 30, 2021 | -8.09% |
Immucell FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();